BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29357321)

  • 21. Immunohistochemical expression of beta-human chorionic gonadotropin in colorectal carcinoma.
    Kido A; Mori M; Adachi Y; Yukaya H; Ishida T; Sugimachi K
    Surg Today; 1996; 26(12):966-70. PubMed ID: 9017956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
    Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
    World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.
    Su F; Wang BF; Zhang T; Hou XM; Feng MH
    Cancer Biomark; 2019; 26(4):451-460. PubMed ID: 31640089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
    Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
    Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.
    Chen H; Liu Y; Jiang CJ; Chen YM; Li H; Liu QA
    Med Sci Monit; 2019 Jun; 25():4176-4185. PubMed ID: 31164625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.
    Jing X; Wu H; Cheng X; Chen X; Zhang Y; Shi M; Zhang T; Wang X; Zhao R
    Scand J Gastroenterol; 2018 Aug; 53(8):964-971. PubMed ID: 30102091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
    Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
    Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.
    Wang SY; Gao K; Deng DL; Cai JJ; Xiao ZY; He LQ; Jiao HL; Ye YP; Yang RW; Li TT; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Jan; 7(3):2878-88. PubMed ID: 26701208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
    Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
    Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
    Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
    Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer.
    Luo Y; Ye GY; Qin SL; Mu YF; Zhang L; Qi Y; Qiu YE; Yu MH; Zhong M
    Int J Biochem Cell Biol; 2016 Jun; 75():53-62. PubMed ID: 27046094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer.
    Lin XL; Yang L; Fu SW; Lin WF; Gao YJ; Chen HY; Ge ZZ
    Oncotarget; 2017 May; 8(20):33586-33600. PubMed ID: 28422720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.
    Liu G; Zhu J; Yu M; Cai C; Zhou Y; Yu M; Fu Z; Gong Y; Yang B; Li Y; Zhou Q; Lin Q; Ye H; Ye L; Zhao X; Li Z; Chen R; Han F; Tang C; Zeng B
    J Transl Med; 2015 May; 13():144. PubMed ID: 25947346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathway.
    Tan F; Zhu H; Tao Y; Yu N; Pei Q; Liu H; Zhou Y; Xu H; Song X; Li Y; Zhou Z; He X; Zhang X; Pei H
    J Exp Clin Cancer Res; 2015 Oct; 34():117. PubMed ID: 26452645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.